Related Experiment Videos
Plasma-motilin in carcinoid tumours
Lancet (London, England)
|November 5, 1977
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors.
European journal of nuclear medicine and molecular imaging·2015
The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract.
The American journal of gastroenterology·2015
Gene transcript analysis blood values correlate with ⁶⁸Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status.
European journal of nuclear medicine and molecular imaging·2015
Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy.
Purinergic signalling·2011
The impact of lymphovascular space invasion on recurrence and survival rate among women with stage I endometrioid endometrial cancer.
The Medical journal of Malaysia·2026
Prognostic Value of Systemic Inflammatory Markers in Predicting Peritoneal Metastasis in Gastric and Gastroesophageal Junction Cancer.
Clinical and translational science·2026